Company Filing History:
Years Active: 2020-2022
Title: Innovations of Hongli Ma in Antibody Development
Introduction
Hongli Ma is a notable inventor based in Taicang, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of two patents to his name, his work focuses on innovative solutions for treating diseases, including cancer.
Latest Patents
Hongli Ma's latest patents include the development of Anti-CD4 antibodies. This patent provides anti-CD4 antibodies or antigen-binding fragments, isolated polynucleotides encoding the same, pharmaceutical compositions comprising these antibodies, and their various uses. Another significant patent is for Anti-CTLA4 antibodies, which are designed to block the binding of CTLA4 to its ligand. These antibodies offer potential agents for treating diseases such as cancer.
Career Highlights
Throughout his career, Hongli Ma has worked with Crown Bioscience Inc., where he has contributed to advancing research in antibody development. His expertise in this area has positioned him as a key figure in the biotechnology sector.
Collaborations
Hongli Ma has collaborated with notable colleagues, including Ziyong Sun and Wencui Ma, who have contributed to his research endeavors.
Conclusion
Hongli Ma's innovative work in the field of antibody development showcases his commitment to advancing medical science. His patents reflect significant advancements that could lead to improved treatments for serious diseases.